European Heart Journal,
Journal Year:
2022,
Volume and Issue:
43(43), P. 4548 - 4561
Published: Aug. 24, 2022
Novel
bio-therapeutic
agents
that
harness
the
properties
of
small,
non-coding
nucleic
acids
hold
great
promise
for
clinical
applications.
These
include
antisense
oligonucleotides
inhibit
messenger
RNAs,
microRNAs
(miRNAs),
or
long
RNAs;
positive
effectors
miRNA
pathway
(short
interfering
RNAs
and
mimics);
small
target
proteins
(i.e.
aptamers).
new
therapies
also
offer
exciting
opportunities
cardiovascular
diseases
to
move
field
towards
more
precise
approaches
based
on
disease
mechanisms.
There
have
been
substantial
advances
in
developing
chemical
modifications
improve
vivo
pharmacological
reduce
their
immunogenicity.
Carrier
methods
(e.g.
RNA
conjugates,
polymers,
lipoplexes)
enhance
cellular
uptake
therapeutics
stability
against
degradation
by
intracellular
nucleases
are
transforming
field.
A
number
indications
now
approved.
Moreover,
there
is
a
large
pipeline
development
an
even
larger
list
putative
emerging
from
pre-clinical
studies.
Progress
this
area
reviewed
herein
along
with
hurdles
need
be
overcome
allow
broader
translation.
Cells,
Journal Year:
2022,
Volume and Issue:
11(12), P. 1935 - 1935
Published: June 15, 2022
Systemic
inflammation
can
be
triggered
by
infection,
surgery,
trauma
or
burns.
During
systemic
inflammation,
an
overshooting
immune
response
induces
tissue
damage
resulting
in
organ
dysfunction
and
mortality.
Endothelial
cells
make
up
the
inner
lining
of
all
blood
vessels
are
critically
involved
maintaining
integrity
regulating
perfusion.
Permeability
endothelial
monolayer
is
strictly
controlled
highly
organ-specific,
forming
continuous,
fenestrated
discontinuous
capillaries
that
orchestrate
extravasation
fluids,
proteins
solutes
to
maintain
homeostasis.
In
physiological
state,
barrier
maintained
glycocalyx,
extracellular
matrix
intercellular
junctions
including
adherens
tight
junctions.
As
constantly
sensing
responding
environment,
their
activation
inflammatory
stimuli
promotes
a
loss
function,
which
has
been
identified
as
hallmark
leading
edema
formation
hypotension
thus,
key
contributor
lethal
outcomes.
this
review,
we
provide
comprehensive
summary
major
players,
such
angiopoietin-Tie2
signaling
axis,
adrenomedullin
vascular
(VE-)
cadherin,
substantially
contribute
regulation
dysregulation
permeability
during
elucidate
treatment
strategies
targeting
preservation
integrity.
Journal of the American Chemical Society,
Journal Year:
2022,
Volume and Issue:
144(13), P. 5685 - 5701
Published: March 24, 2022
Cryopreservation
of
tissues
and
organs
can
bring
transformative
changes
to
medicine
medical
science.
In
the
past
decades,
limited
progress
has
been
achieved,
although
cryopreservation
long
intensively
pursued.
One
key
reason
is
that
cryoprotective
agents
(CPAs)
currently
used
for
cell
cannot
effectively
preserve
because
their
cytotoxicity
tissue
destructive
effect
as
well
low
efficiency
in
controlling
ice
formation.
stark
contrast,
nature
its
unique
ways
formation,
many
living
organisms
prevent
freezing
damage.
Ice-binding
proteins
(IBPs)
are
regarded
essential
materials
identified
these
regulating
nucleation
growth.
Note
controversial
results
have
reported
on
utilization
IBPs
mimics
organs,
is,
some
groups
revealed
exhibited
superiorities
cryopreservation,
while
other
showed
detrimental
effects.
this
perspective,
we
analyze
possible
reasons
controversy
predict
future
research
directions
design
construction
IBP
inspired
ice-binding
be
new
CPAs
after
briefly
introducing
cryo-injuries
challenges
conventional
organs.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 4, 2023
Abstract
Lipid‐based
nanoparticles
(LBNPs)
are
currently
the
most
promising
vehicles
for
nucleic
acid
drug
(NAD)
delivery.
Although
their
clinical
applications
have
achieved
success,
NAD
delivery
efficiency
and
safety
still
unsatisfactory,
which
are,
to
a
large
extent,
due
existence
of
multi‐level
physiological
barriers
in
vivo.
It
is
important
elucidate
interactions
between
these
LBNPs,
will
guide
more
rational
design
efficient
with
low
adverse
effects
facilitate
broader
therapeutics.
This
review
describes
obstacles
challenges
biological
at
systemic,
organ,
sub‐organ,
cellular,
subcellular
levels.
The
strategies
overcome
comprehensively
reviewed,
mainly
including
physically/chemically
engineering
LBNPs
directly
modifying
by
auxiliary
treatments.
Then
potentials
successful
translation
preclinical
studies
into
clinic
discussed.
In
end,
forward
look
on
manipulating
protein
corona
(PC)
addressed,
may
pull
off
trick
overcoming
those
significantly
improve
efficacy
LBNP‐based
NADs
Cells,
Journal Year:
2023,
Volume and Issue:
12(13), P. 1778 - 1778
Published: July 4, 2023
CD93
(also
known
as
complement
protein
1
q
subcomponent
receptor
C1qR1
or
C1qRp),
is
a
transmembrane
glycoprotein
encoded
by
gene
located
on
20p11.21
and
composed
of
652
amino
acids.
can
be
present
in
two
forms:
soluble
(sCD93)
membrane-bound
(CD93).
mainly
expressed
endothelial
cells,
where
it
plays
key
role
promoting
angiogenesis
both
physiology
disease,
such
age-related
macular
degeneration
tumor
angiogenesis.
In
fact,
highly
tumor-associated
vessels
its
presence
correlates
with
poor
prognosis,
immunotherapy
response,
immune
cell
infiltration
high
tumor,
node
metastasis
(TNM)
stage
many
cancer
types.
also
hematopoietic
stem
cytotrophoblast
platelets
i.e.,
monocytes,
neutrophils,
B
cells
natural
killer
(NK)
cells.
Accordingly,
involved
modulating
important
inflammatory-associated
diseases
including
systemic
sclerosis
neuroinflammation.
Finally,
cardiovascular
disease
development
progression.
this
article,
we
reviewed
the
current
literature
regarding
angiogenesis,
inflammation
growth
order
to
understand
could
potential
therapeutic
target
modify
outcome
abovementioned
pathologies.
European journal of medical research,
Journal Year:
2023,
Volume and Issue:
28(1)
Published: Sept. 12, 2023
Abstract
Background
Lipopolysaccharide,
a
highly
potent
endotoxin
responsible
for
severe
sepsis,
is
the
major
constituent
of
outer
membrane
gram-negative
bacteria.
Endothelial
cells
participate
in
both
innate
and
adaptive
immune
responses
as
first
cell
types
to
detect
lipopolysaccharide
or
other
foreign
debris
bloodstream.
are
able
recognize
presence
LPS
recruit
specific
adaptor
proteins
domains
TLR4,
thereby
initiating
an
intracellular
signaling
cascade.
However,
binding
endothelial
induces
activation
even
damage,
manifested
by
expression
proinflammatory
cytokines
adhesion
molecules
that
lead
sepsis.
Main
findings
involved
local
systemic
inflammation,
activating
immunity.
Translocation
into
circulation
causes
endotoxemia.
dysfunction,
including
exaggerated
coagulopathy
vascular
leakage,
may
play
central
role
dysregulated
host
response
pathogenesis
By
discussing
many
strategies
used
treat
this
review
attempts
provide
overview
how
ever
more
complex
syndrome
sepsis
potential
development
novel
therapeutics.
Conclusions
To
reduce
patient
morbidity
mortality,
preservation
function
would
be
management
Graphical